These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 22440368)

  • 21. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.
    Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A
    Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion.
    Kiliçgün A; Turna A; Sayar A; Solak O; Urer N; Gürses A
    Thorac Cardiovasc Surg; 2010 Mar; 58(2):93-7. PubMed ID: 20333571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
    Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
    Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer.
    Ng T; Ryder BA; Chern H; Sellke FW; Machan JT; Harrington DT; Cioffi WG
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):815-9. PubMed ID: 22325327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
    Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
    Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of prognostic factors in 1826 patients with completely resected non-small cell lung cancer].
    Gao YS; Xing XZ; Shao K; Feng XL; He J
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):134-7. PubMed ID: 18646698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology?
    Kawachi R; Nakazato Y; Masui K; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):265-8. PubMed ID: 19429636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor recurrence after complete resection for non-small cell lung cancer.
    Taylor MD; Nagji AS; Bhamidipati CM; Theodosakis N; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2012 Jun; 93(6):1813-20; discussion 1820-1. PubMed ID: 22542070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms.
    Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A
    Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.